Hemodynamic Monitoring
0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Edwards LifesciencesCA - Irvine
2 programsAcumenTM Hypotension Prediction Index softwareN/A1 trial
invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards LifesciencesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Baxter InternationalStarling
Medica Corphemodynamic continuous monitoring
Edwards LifesciencesAcumenTM Hypotension Prediction Index software
Baxter InternationalStarling
Edwards Lifesciencesinvasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences
Clinical Trials (5)
Total enrollment: 2,198 patients across 5 trials
Starling/CRRT Observational Study
Start: Jul 2023Est. completion: Mar 20250
N/AWithdrawn
Hemodynamic and Cerebral Effects Evaluation in Anesthesia
Start: Oct 2022Est. completion: Jul 2024100 patients
N/AUnknown
The EU Hyprotect Registry
Start: Sep 2021Est. completion: Sep 2022702 patients
N/ACompleted
Starling Registry Study
Start: Nov 2020Est. completion: Feb 20241,207 patients
N/ACompleted
NCT02950649Edwards Lifesciencesinvasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences
Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care
Start: Nov 2016Est. completion: Jun 2021189 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.